Pure Global
Disease/Condition
16 Clinical Trials
6+ Countries

Cutaneous Lupus Erythematosus Clinical Trials Database - Free Access to 16 Studies

Access comprehensive clinical trial information for Cutaneous Lupus Erythematosus through Pure Global AI's free database. This collection includes 16 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 2 trials are actively recruiting participants.

Research for Cutaneous Lupus Erythematosus is being conducted in United States of America, Germany, Argentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk and 3+ other countries. Leading sponsors include Gilead Sciences and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
Phase 2
6
N/A
6
Phase 1
2
Early Phase 1
1
Phase 3
1
By Status
Completed
10
Recruiting
2
Terminated
2
Not yet recruit...
1
Suspended
1
Top Countries
United States of America7
Germany3
Argentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk1
Canada,Moldova - Republic of,United States of America1
Canada,United States of America1
Top Sponsors
Gilead Sciences2
AstraZeneca1
Ben Chong1
Centre for Human D...1
Emory University1
Recent Trials
Latest clinical trials for Cutaneous Lupus Erythematosus
NCT06411106
Recruiting

Deep Phenotyping of Cutaneous Lupus Erythematosus

Centre for Human Drug Research...Netherlands
NCT06015737
Phase 3
Not yet recr...

A Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

AstraZeneca
2020-004703-14
Completed

A randomized, double-blind, placebo controlled, proof of concept study assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with moderate to severe subacute or discoid/chronic cutaneous lupus erythematosus

Sanofi-Aventis Recherche & Dév...
NCT04809623
Phase 1
Suspended

Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)

Gilead SciencesUnited States of America
NCT04781816
Phase 2
Recruiting

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

SanofiArgentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk
NCT03134222
Phase 2
Completed

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Gilead SciencesCanada,United States of America
NCT01841619
Early Phase 1
Completed

IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

University of California, Irvi...United States of America
NCT01776190
Completed

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Ben ChongUnited States of America
NCT01629784
Completed

Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus

Northwestern UniversityUnited States of America
NCT01498406
Phase 2
Terminated

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Emory UniversityUnited States of America
NCT01470313
Phase 1
Terminated

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

PfizerCanada,Moldova - Republic of,United States of America
NCT01300208
Phase 2
Completed

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

AmgenUnited States of America
NCT01146444
Completed

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

Spirig Pharma Ltd.Germany
NCT00523588
Phase 2
Completed

Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser

University of PennsylvaniaUnited States of America
NCT00420173
Completed

Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

European Society of Cutaneous ...Germany
NCT00317681
Phase 2
Completed

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Heinrich-Heine University, Due...Germany
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Cutaneous Lupus Erythematosus Research

Pure Global AI provides free access to 16 clinical trials studying Cutaneous Lupus Erythematosus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 6+ countries.

Top research sponsors include Gilead Sciences, AstraZeneca, Ben Chong, among others.

Quick Facts
Total Trials16
Countries6+
Sponsors10+
Recruiting2